Lonza
Fatma Aybegum Senkesen is a seasoned professional in the field of market intelligence and strategic marketing, currently serving as the Head of PMO and holding various leadership roles at Lonza since December 2013. With extensive experience in Cell and Gene Therapy Manufacturing, Fatma has led teams focused on market analysis, portfolio management, and business planning. Previous positions include Associate Director of Market Research and Intelligence for Emerging Technologies and Senior Manager of Market Intelligence at QTM Enterprises, where Fatma provided consultancy services in the healthcare sector. Fatma co-founded the Market Analytics Group, specializing in primary and secondary market research for pharmaceutical products. Early career experience includes work in the Marketing Science Department at Noven Pharmaceuticals. Educational qualifications include an MBA in Marketing and Management Science from the University of Miami and a BS in Chemistry from Boğaziçi University.
This person is not in any teams
This person is not in any offices
Lonza
68 followers
Lonza Group AG (Lonza) is a Switzerland-based holding company and a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The Life Science Ingredients division comprises a range of products for applications in nutrition, hygiene, preservation, water treatment, materials protection, and other industrial markets. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics.